SlateStone Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,386	Closed	-$304K	–	204
2022 Q1	$304K	Sell	3,386 -14,750	-81%	-$1.36M	0.07%	144
2021 Q4	$2.03M	Hold	18,136	–	–	0.43%	56
2021 Q3	$2.28M	Sell	18,136 -3,600	-17%	-$464K	0.52%	45
2021 Q2	$2.94M	Sell	21,736 -300	-1%	-$39.4K	0.67%	37
2021 Q1	$2.99M	Hold	22,036	–	–	0.74%	38
2020 Q4	$3.1M	Buy	22,036 +150	+0.7%	+$19.2K	0.77%	33
2020 Q3	$2.44M	Hold	21,886	–	–	0.53%	54
2020 Q2	$2.45M	Hold	21,886	–	–	0.55%	53
2020 Q1	$1.7M	Sell	21,886 -400	-2%	-$35.4K	0.48%	58
2019 Q4	$2.12M	Sell	22,286 -450	-2%	-$38.9K	0.48%	55
2019 Q3	$1.73M	Sell	22,736 -85	-0.4%	-$7.06K	0.51%	53
2019 Q2	$2M	Hold	22,821	–	–	0.56%	46
2019 Q1	$2.07M	Buy	22,821 +835	+4%	+$71K	0.63%	37
2018 Q4	$1.58M	Buy	+21,986	New	+$1.77M	0.73%	38